Comparison of 2-year clinical outcomes between zotarolimus-, sirolimus-, and paclitaxel-eluting stents in real life clinical practice.

about

Comparison of 2-year clinical outcomes between zotarolimus-, sirolimus-, and paclitaxel-eluting stents in real life clinical practice.

Item

http://www.wikidata.org/entity/Q44517017

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Comparison of 2-year clinical ...... n real life clinical practice.

@en

Comparison of 2-year clinical ...... n real life clinical practice.

@nl

type

Item

label

Comparison of 2-year clinical ...... n real life clinical practice.

@en

Comparison of 2-year clinical ...... n real life clinical practice.

@nl

prefLabel

Comparison of 2-year clinical ...... n real life clinical practice.

@en

Comparison of 2-year clinical ...... n real life clinical practice.

@nl

P1476

Comparison of 2-year clinical ...... n real life clinical practice.

@en

P2093

Dong-Ho Shin

http://www.w3.org/2001/XMLSchema#string

Dong-Ju Choi

http://www.w3.org/2001/XMLSchema#string

Hyo-Soo Kim

http://www.w3.org/2001/XMLSchema#string

In-Ho Chae

http://www.w3.org/2001/XMLSchema#string

Ji-Hyun Kim

http://www.w3.org/2001/XMLSchema#string

Kyung Woo Park

http://www.w3.org/2001/XMLSchema#string

P2860

Safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice: 12-month data from the E-Five registry.

Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts

Propensity scores in cardiovascular research.

The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents.

Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.

2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.

Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial.

Does "late catch-up" exist in drug-eluting stents: insights from a serial quantitative coronary angiography analysis of sirolimus versus paclitaxel-eluting stents.

A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial.

Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.

P304

349-359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CCD.23428

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Woo-Hyun Lim

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24654284

http://www.w3.org/2001/XMLSchema#string